The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival
2016 · Nature Communications · 107 citations
https://doi.org/10.1038/ncomms10258
H
Hideo Harigae
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
503
Papers
8.1K
Citations
42
h-index
206
i10-index
Hideo Harigae is an academic researcher from Tohoku University Hospital. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research & Immune Cell Function and Interaction. The author has an h-index of 42, co-authored 428 publications.
ORCID: 0000-0003-4849-7442Papers by this author
worksQuantitative Analysis of a MDR1 Transcript for Prediction of Drug Resistance in Acute Leukemia
2002 · Clinical Chemistry · 36 citations
https://doi.org/10.1093/clinchem/48.6.811
Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
2009 · Rheumatology International · 29 citations
https://doi.org/10.1007/s00296-009-1095-0
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis
2013 · Experimental Hematology and Oncology · 24 citations
https://doi.org/10.1186/2162-3619-2-19
Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia
2015 · Retrovirology · 23 citations
https://doi.org/10.1186/s12977-015-0225-x
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
2022 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-022-18921-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat